Tools

Print
Text

Scleroderma means hard skin. It is a group of diseases that cause abnormal growth of connective tissue.

Programs + Services | Doctors + Care Team | Research + Clinical Trials | News

Programs + Services

Dermatology

Looking for a dermatologist in Boston? Our top rated dermatologists provide innovative treatment for a variety of skin conditions, including cosmetic procedures and treatments for skin conditions and skin cancer.
More information about programs and services

Rheumatology

The Division of Rheumatology at Tufts Medical Center in Boston offers comprehensive evaluation, consultation and management of arthritis and rheumatic disease.
More information about programs and services

Medical Dermatology Clinic

The Medical Dermatology Clinic at Tufts Medical Center in downtown Boston evaluates and manages a broad range of dermatologic conditions that require medical care, including acne, warts, and more. Learn more and request an appointment.
More information about programs and services

Doctors + Care Team

Timothy E. McAlindon, MD, MPH

Loading ...

Accepting New Patients

Virtual Appointments Available

Online Scheduling Available

Title(s): Chief, Division of Rheumatology; Professor, Tufts University School of Medicine
Department(s): Medicine, Rheumatology, Allergy and Immunology
Appt. Phone: 617-636-5990
Fax #: 617-636-2388

Osteoarthritis, general rheumatology, lupus

View Full Profile for Timothy E. McAlindon, MD, MPH

Gabriela A. Cobos, MD

Accepting New Patients

Online Scheduling Available

Title(s): Dermatologist; Director of Clinical Trials; Director of the Dermatology-Rheumatology Program; Associate Outpatient Medical Director
Department(s): Dermatology
Appt. Phone: 617-636-0156
Fax #: 617-636-9169

Psoriasis, Atopic Dermatitis, Connective Tissue Diseases, Cutaneous Lupus, Dermatomyositis, Sclerosing disorders, Scleroderma, Systemic Sclerosis, Morphea, Eosinophilic Fasciitis, Pityriasis Rubra Pilaris, Vasculitis

View Full Profile for Gabriela A. Cobos, MD

David S. Feingold, MD

Loading ...

Accepting New Patients

Online Scheduling Available

Title(s): Dermatologist-in-Chief, Emeritus; Professor Emeritus, Tufts University School of Medicine
Department(s): Dermatology
Appt. Phone: 617-636-0156
Fax #: 617-636-9169

Cutaneous infections, medical dermatology

View Full Profile for David S. Feingold, MD

William F. Harvey, MD, MSc, FACR

Loading ...

Accepting New Patients

Virtual Appointments Available

Online Scheduling Available

Title(s): Clinical Director, Rheumatology; Rheumatologist; Assistant Professor, Tufts University School of Medicine
Department(s): Medicine, Rheumatology, Allergy and Immunology
Appt. Phone: 617-636-5990
Fax #: 617-636-2388

Osteoarthritis, general rheumatology, musculoskeletal ultrasound

View Full Profile for William F. Harvey, MD, MSc, FACR

Robert A. Kalish, MD

Loading ...

Accepting New Patients

Virtual Appointments Available

Online Scheduling Available

Title(s): Director, Rheumatology Education; Associate Professor, Tufts University School of Medicine
Department(s): Medicine, Rheumatology, Allergy and Immunology
Appt. Phone: 617-636-5990
Fax #: 617-636-2388

General rheumatology, Lyme disease

View Full Profile for Robert A. Kalish, MD

Jeffrey M. Sobell, MD

Loading ...

Accepting New Patients

Online Scheduling Available

Title(s): Dermatologist; Associate Professor, Tufts University School of Medicine
Department(s): Dermatology
Appt. Phone: 617-636-0156
Fax #: 617-636-8412

Medical dermatology, psoriasis, phototherapy

View Full Profile for Jeffrey M. Sobell, MD

Steven C. Vlad, MD, PhD

Loading ...

Accepting New Patients

Virtual Appointments Available

Online Scheduling Available

Title(s): Rheumatologist; Assistant Professor, Tufts University School of Medicine
Department(s): Medicine, Rheumatology, Allergy and Immunology
Appt. Phone: 617-636-5990
Fax #: 617-636-2388

General rheumatology, spondyloarthropathies, psoriatic arthritis and anklylosing spondylitis

View Full Profile for Steven C. Vlad, MD, PhD

Research + Clinical Trials

A Phase II, randomised, placebo-controlled, double-blind, parallel-group, efficacy and safety study of at least 48 weeks of oral BI 685509 treatment in adults with early progressive diffuse cutaneous systemic sclerosis

The objective of the trial is to assess the efficacy, safety, and tolerability of BI 685509 compared with placebo on a background of local standard of care (SOC) therapy in the treatment of adult patients with early progressive dcSSc and vasculopathy
More information about research and clinical trials